Clinical Trial Update: "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment " [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant palbociclib and its effects on Ki67 and apoptosis in breast neoplasms before, during, and after treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Fondazione Michelangelo | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED